Literature DB >> 33894683

Set Shifting and Inhibition Deficits as Potential Endophenotypes for Depression.

Huiting Liu1, Carter J Funkhouser2, Scott A Langenecker3, Stewart A Shankman4.   

Abstract

The etiology of Major Depressive Disorder (MDD) is poorly understood, and identifying endophenotypes, or intermediate processes implicated in pathophysiology, for MDD may inform treatment and identification/prevention efforts. Impaired set-shifting and inhibition are commonly observed in MDD; however, few studies have examined they are endophenotypes for MDD. Thus, the present study tested whether set-shifting and/or inhibition satisfy several endophenotype criteria: specifically, whether they were (1) impaired in current MDD, (2) impaired in remitted MDD, and (3) familial (i.e., correlated within sibling pairs). Set-shifting and inhibition were assessed using subtests from the Delis-Kaplan Executive Function System. Psychopathology was assessed using the Structured Clinical Interview for DSM-5. Results indicated set-shifting deficits were familial and present in both current MDD and in remitted MDD individuals who had no current disorders, suggesting they may be state-independent. Inhibition was familial, but was generally not impaired in current nor remitted MDD (although the remitted MDD group with no current disorders exhibited impairments on one of the two inhibition tasks). These findings indicate that impaired set-shifting is a promising endophenotype candidate for MDD. Findings are limited to young adults, and further research is needed to test generalizability to other populations, evaluate longitudinal relationships, and examine other endophenotype criteria.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cognition; Executive functioning; Remission; Risk; Vulnerability

Mesh:

Year:  2021        PMID: 33894683      PMCID: PMC8141023          DOI: 10.1016/j.psychres.2021.113931

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   11.225


  60 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  Is the Wisconsin Card Sorting Test a useful neurocognitive endophenotype?

Authors:  William S Kremen; Seth A Eisen; Ming T Tsuang; Michael J Lyons
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-06-05       Impact factor: 3.568

3.  An approximate distribution of estimates of variance components.

Authors:  F E SATTERTHWAITE
Journal:  Biometrics       Date:  1946-12       Impact factor: 2.571

4.  The time course of responding to aversiveness in females with a history of non-suicidal self-injury.

Authors:  Carter J Funkhouser; Kelly A Correa; Vivian L Carrillo; David M Klemballa; Stewart A Shankman
Journal:  Int J Psychophysiol       Date:  2019-04-25       Impact factor: 2.997

5.  Cognitive deficits in the remitted state of unipolar depressive disorder.

Authors:  Bo Jacob Hasselbalch; Ulla Knorr; Steen Gregers Hasselbalch; Anders Gade; Lars Vedel Kessing
Journal:  Neuropsychology       Date:  2012-07-23       Impact factor: 3.295

6.  Attentional functions in major depressive disorders with and without comorbid anxiety.

Authors:  P Lyche; R Jonassen; T C Stiles; P Ulleberg; N I Landrø
Journal:  Arch Clin Neuropsychol       Date:  2010-12-10       Impact factor: 2.813

7.  INFLEXIBLE COGNITION PREDICTS FIRST ONSET OF MAJOR DEPRESSIVE EPISODES IN ADOLESCENCE.

Authors:  Jonathan P Stange; Samantha L Connolly; Taylor A Burke; Jessica L Hamilton; Elissa J Hamlat; Lyn Y Abramson; Lauren B Alloy
Journal:  Depress Anxiety       Date:  2016-04-19       Impact factor: 6.505

Review 8.  Systematic review of school-based prevention and early intervention programs for depression.

Authors:  Alison L Calear; Helen Christensen
Journal:  J Adolesc       Date:  2009-07-31

9.  Neurocognition in individuals at high familial risk of mood disorders with or without subsequent onset of depression.

Authors:  M Papmeyer; J E Sussmann; J Hall; J McKirdy; A Peel; A Macdonald; S M Lawrie; H C Whalley; A M McIntosh
Journal:  Psychol Med       Date:  2015-07-20       Impact factor: 7.723

10.  A follow-up study of first episode major depressive disorder. Impairment in inhibition and semantic fluency-potential predictors for relapse?

Authors:  Marit Schmid; Asa Hammar
Journal:  Front Psychol       Date:  2013-09-13
View more
  2 in total

1.  Computerized Working Memory Training in Remission From Major Depressive Disorder: Effects on Emotional Working Memory, Processing Speed, Executive Functions, and Associations With Symptoms.

Authors:  Eivind Haga Ronold; Jutta Joormann; Åsa Hammar
Journal:  Front Behav Neurosci       Date:  2022-06-27       Impact factor: 3.617

2.  Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

Authors:  Manoj K Doss; Michal Považan; Monica D Rosenberg; Nathan D Sepeda; Alan K Davis; Patrick H Finan; Gwenn S Smith; James J Pekar; Peter B Barker; Roland R Griffiths; Frederick S Barrett
Journal:  Transl Psychiatry       Date:  2021-11-08       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.